Precision BioSciences ($DTIL)

Description

Develops ARCUS genome-editing medicines that insert, remove, or repair DNA, targeting hard-to-treat conditions including Duchenne muscular dystrophy and hepatitis B.

Related

• LEO Pharma A/SLEO Pharma researches, develops, and delivers medicines for skin diseases.
• ARTHEX BIOTECH S.L.Develops RNA-based therapeutics, specifically anti-miR oligonucleotides for myotonic dystrophy and other diseases, used by researchers and…
• Metagenomi ($MGX)Develops in vivo genome-editing systems derived from metagenomics to create genetic medicines intended to correct disease-causing mutations…
• Agomab TherapeuticsAgomab develops biopharmaceutical therapies for fibro-inflammatory conditions, targeting the TGFß/ALK5 pathway and advancing candidates for…
• Relay Therapeutics ($RLAY)Develops small molecule medicines using computational and experimental protein-motion analysis, targeting previously hard-to-drug precision…
• Poseida Therapeutics (Roche)Develops cell therapy candidates and related platform technologies, with legacy programs in a biotechnology pipeline for medicines…
• Arbor BiotechnologiesDevelops gene editing treatments and genetic medicines using programmable DNA editors for people with genetic diseases, with a focus on CNS…
• NewLimitDevelops medicines using AI-designed payloads and genomics testing to restore youthful function in old cells, targeting age-related…
• PhosPrint SADevelops laser bioprinting systems for precise delivery of cells and bio-inks, used for regenerative medicine and biosensor applications…
• FarmWiseBuilds AI and computer vision weeding equipment, including an intra-row weeder and precision cultivator, to help farmers remove weeds in…
• Sana Biotechnology ($SANA)Builds engineered cell medicines that repair or control genes, or replace damaged cells, for patients with diseases including diabetes,…
• Northern Lights JV DANorthern Lights provides carbon dioxide transport and storage services.